PROMIS NEUROSCIENCES INC. Payments to Acquire Short-term Investments
PROMIS NEUROSCIENCES INC. (PMN) reported Payments to Acquire Short-term Investments of $33.75 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2026-03-25
- PROMIS NEUROSCIENCES INC. payments to acquire short-term investments for fiscal 2025 was $33.75K, a 2.12% increase from fiscal 2024.
- PROMIS NEUROSCIENCES INC. payments to acquire short-term investments for fiscal 2024 was $33.05K, a 2.14% increase from fiscal 2023.
- PROMIS NEUROSCIENCES INC. payments to acquire short-term investments for fiscal 2023 was $32.36K, a 4.35% increase from fiscal 2022.
- PROMIS NEUROSCIENCES INC. payments to acquire short-term investments for fiscal 2022 was $31.01K, a 6.32% decline from fiscal 2021.
| Period end | Payments to Acquire Short-term Investments 12 month |
|---|---|
| 2025-12-31 | $33.75K 10-K · filed 2026-03-25 |
| 2024-12-31 | $33.05K 10-K · filed 2026-03-25 |
| 2023-12-31 | $32.36K 10-K · filed 2025-03-31 |
| 2022-12-31 | $31.01K 10-K · filed 2024-04-01 |
| 2021-12-31 | $33.10K 10-K · filed 2023-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |